Urological oncology: prostate

27/01/2018

Hof Ter Musschen

 

Chair: L. Renard

09:00 – 09:30

Radiological work-up (diagnosis, staging and follow-up)

P. De Visschere (UZ Gent)

09:30 – 09:50

Pathology : the new classification

L. Libbrecht (UCL St.-Luc)

09:50 – 10:30

Prostate screening and Active Surveillance - treatment tree decision B. Tombal (UCL St.-Luc)

10:30 – 11:00

Coffee break

 

11:00 – 12:00

Radiotherapy:

  • Technical aspects : delineation, DVH, dose prescription
  • Indication
  • Results/toxicity

P. Dirix (Iridium Kankernetwerk)

12:00 – 12:30

Systemic treatment

J.-P. Machiels (UCL St.-Luc)

 

The AFCN/FANC has attributed 2 hours to Radiation Oncologists for the required continuous education in radiation protection of the patient.

 

Registration deadline: January 18, 2018

Lymphoma: HK + non HK disease (+ TBI)

16/12/2017

Hof Ter Musschen

 

Chair: P. Meijnders

09:00 – 09:15

Introduction

P. Meijnders (Iridium Kankernetwerk)

09:15 – 10:15

Epidemiology, pathology, general treatment principles

R. Schots (UZ Brussel)

10:15 – 10:30

Coffee break

 

10:30 – 12:00

Radiotherapy: indications, techniques, results, late effects

P. Meijnders (Iridium Kankernetwerk)

12:00 – 12:30

TBI

P. Meijnders (Iridium Kankernetwerk)

 

The AFCN/FANC has attributed 3 hours to Radiation Oncologists for the required continuous education in radiation protection of the patient.

 

Registration deadline: December 07, 2017

Paediatrics

25/11/2017

Hof Ter Musschen - room "Luscinia"

 

Chair: T. Boterberg

09:00 – 09:30

Paediatric oncology for the radiation oncologist

C. Dhooge (UZ Gent)

09:30 – 10:15

Sarcoma

X. Geets (UCL St.-Luc)

10:15 – 10:45

Wilms’ tumour

T. Boterberg (UZ Gent)

10:45 – 11:15

Coffee break

 

11:15 – 11:45

Neuroblastoma

T. Boterberg (UZ Gent)

11:45 – 12:30

Late effects

T. Boterberg (UZ Gent)

 

The AFCN/FANC has attributed 3 hours to Radiation Oncologists for the required continuous education in radiation protection of the patient.

 

Registration deadline: November 17, 2017

Re-irradiation on brain and head and neck tumours

28/10/2017

Hof Ter Musschen

 

Chairs: V. Grégoire + D. Van den Berge

09:00 – 10:00

Tolerance of brain and head and neck normal tissues to retreatment

W. Doerr (Medical University of Vienna)

10:00 – 11:30

Head & Neck tumours

10:00 – 10:15

Imaging of recurrent head and neck tumours

Th. Duprez (UCL St.-Luc)

10:15 – 10:45

Coffee break

 

10:45 – 11:30

Re-irradiation of recurrent head and neck tumours

V. Grégoire (UCL St.-Luc)

11:30 – 12:30

Brain tumours

11:30 – 11:45

Imaging of recurrent brain tumours

D. Van den Berge (UZ Brussel)

11:45 – 12:30

Re-irradiation of brain tumours

D. Van den Berge (UZ Brussel)

 

The AFCN/FANC has attributed 2 hours to Radiation Oncologists for the required continuous education in radiation protection of the patient.

 

Registration deadline: October 19, 2017

ADVISORY REPORT 9349

The use of low energy RX devices for therapeutic purposes

Short description: This scientific advisory report of the SHC aims at providing recommendations to the Nuclear Control Authorities on the justified use of low energy X-ray devices for therapeutic purposes.

 

AVIS 9349

Utilisation des appareils RX de basse énergie à des fins thérapeutiques

Brève description : Cet avis scientifique du CSS vise à  formuler, à l'intention de l'Agence fédérale de contrôle nucléaire, des recommandations quant à l'utilisation justifiée des appareils RX de basse énergie à des fins thérapeutiques.

L'avis complet en français

 

ADVIES 9349

Het gebruik van laagenergetische röntgentoestellen voor  therapeutische doeleinden

Korte omschrijving: Het doel van dit wetenschappelijk advies van de HGR is om aanbevelingen te formuleren ten behoeve van het Federaal Agentschap voor Nucleaire Controle over het gerechtvaardigd gebruik van  laagenergetische röntgentoestellen voor  therapeutische doeleinden.

Het volledige advies in het Nederlands

 

 

This advice was published on June 7, 2017.

Page 10 of 20

Belgische Vereniging voor Radiotherapie-Oncologie vzw | Association Belge de Radiothérapie-Oncologie asbl | Siège social - Hoofdkantoor : GBS - VBS, avenue de la Couronne, 20 – Kroonlaan, 20
1050 BRUXELLES – 1050 BRUSSEL,BELGIUM, National Number : 425.705.482, TVA -VAT : BE0.425.705.482

Website by WEBWEAVER.be | Privacy Policy